Aptevo Therapeutics Inc (APVO)
4.81
-0.30
(-5.87%)
USD |
NASDAQ |
Dec 27, 16:00
4.68
-0.13
(-2.70%)
After-Hours: 20:00
Aptevo Therapeutics Research and Development Expense (Quarterly): 3.103M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Trevi Therapeutics Inc | 11.22M |
| Keros Therapeutics Inc | 49.22M |
| Johnson & Johnson | 4.952B |
| Eyenovia Inc | 3.472M |
| Applied Therapeutics Inc | 14.83M |